Special Edition
 Life Science Nation Newsletter  | September 4, 2018   |  Issue 282

 Life Science
Investor Mandates
(Aug. 23 - Aug. 29 )

By Dennis Ford, Founder & CEO, Life Science Nation; Creator of RESI Conference Series

My Boston-based company, Life Science Nation (LSN), was basically frozen out of Biotech Week Boston (BWB) last year. I wrote an article in response to the treatment LSN, and our Redefining Early Stage Investments (RESI) Conference Series September event, received from the London-based owners of BWB. Yes, a London-based company owns Biotech Week Boston! The article tried making the case that it was in the best interest of everyone to make BWB inclusive instead of exclusive if it really wanted to be a JPM-like East Coast event.

As a result of writing the article, I and my company staff were told we were subsequently banned from any and all EBDGroup.knect365 events. Then, a few months ago, I was approached by one of their senior marketing staff with an offer. First, she told me LSN and RESI could be part of the BWB this year's event, but that LSN would have to pay a fee per RESI attendee which would have amounted to over $100 K. Basically, the offer was to list LSN and RESI in their web-based event marketing collateral and have access to some event functions. Next, after my explicit refusal, I was shocked to learn that upon entering "RESI Boston," LSN's premier September event (since 2013) as a search term on Google, a paid advertisement appears, redirecting prospective RESI Boston attendees to EDBGroup's BioPharm America conference "Register Now" page at BWB (see below). In my eyes this is a very dirty trick.

Do the Massachusetts Life Science stalwarts and luminaries who are supporting this BWB conference know that these type of shenanigans are part and parcel of what they are endorsing and sponsoring?

I founded LSN and the RESI Conference Series to help move the needle in life science - to get early-stage life science companies funded and get badly needed treatments and cures to patients who currently have none. If you are a fundraising life science CEO or scientist-entrepreneur looking to fund a new drug, medical device, diagnostic test or digital health product, there will be over 300 global investors and partners that will be attending RESI Boston. Feel free to check out the program guide; Life Science Nation's RESI event is being held on September 6th at the Boston Marriott Copley Place.

It may be time for another Boston tea party.

Created & Produced by
 Life Science
Investor Mandates
(Aug. 23 - Aug. 29 )
Invests in Global Therapeutics and Medical Device Technologies that Address Unmet Medical Needs
with Expanded Interests in Healthcare Seeks to Invest in Healthcare Solutions that Leverage Data and Technology
Invests Up to $10M in Therapeutics and Diagnostics Companies with a Strong China Angle
Allocates Up to $10M in Therapeutics, Medical Device, Diagnostics, and Digital Health Innovations
Invests in Medical Device, Diagnostic, and Digital Health Companies in USA and China
Seeks Novel Therapeutic Candidates Across CNS, Oncology, Liver Disease, and Other Indications Globally
Invests in Novel Therapeutics, Devices, Diagnostics & Life Science Tools
with $300M Fund Invests in North American Life Science Technologies with Strong China Market Potential, with Particular Interest in Vaccines
with $2B RMB AUM Seeks to Invest in Therapeutics and Medical Device Companies with Strong Clinical Efficacy Data
Invests in Global Digital Health Solutions for Chronic Diseases, Consumer & Mental Health, and Other Indications
Life Science Nation Media Partner